Article Information
History
- January 10, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Raphael Gronauer1,
- Leonie Madersbacher1,
- Pablo Monfort-Lanzas1,2,
- Gabriel Floriani1,
- Susanne Sprung4,
- Alain Gustave Zeimet3,
- Christian Marth3,
- Heidelinde Fiegl3 and
- Hubert Hackl1,*
- 1Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Austria
- 2Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Austria
- 3Department of Obstetrics and Gynecology, Medical University of Innsbruck, Austria
- 4Institute of Pathology, Innpath GmbH, Innsbruck, Austria
- ↵*Correspondence: Hubert Hackl, PhD, Institute of Bioinformatics, Biocenter, Medical University of Innsbruck Innrain 80, 6020 Innsbruck, Austria, Email: hubert.hackl{at}i-med.ac.at
Posted January 10, 2024.
Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy
